[{"address1": "Level 10", "address2": "Tower 11 Avenue 5, No. 8 Jalan Kerinchi", "city": "Kuala Lumpur", "zip": "592000", "country": "Malaysia", "phone": "60 9 08517 7330", "website": "https://www.cyclacel.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer medicines based on cell cycle, transcriptional regulation, epigenetics, and mitosis control biology in the United States. Its lead product Plogosertib or plogo, a solid tumors and hematological malignancies, which is in Phase 1/2 clinical trial. The company was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Sing Ee Wong", "age": 43, "title": "Chairman, CEO & President", "yearBorn": 1981, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Cu Seng Kiu", "age": 34, "title": "Executive Director, CFO & Secretary", "yearBorn": 1990, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Gill  Christie", "age": 67, "title": "Director of Human Resources", "yearBorn": 1957, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Grace  Kim", "title": "Investor Relations Executive", "exercisedValue": 0, "unexercisedValue": 0}], "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 7.82, "open": 7.78, "dayLow": 7.74, "dayHigh": 8.82, "regularMarketPreviousClose": 7.82, "regularMarketOpen": 7.78, "regularMarketDayLow": 7.74, "regularMarketDayHigh": 8.82, "payoutRatio": 0.0, "beta": 0.089, "trailingPE": 0.0011560328, "forwardPE": -4.1381907, "volume": 96637, "regularMarketVolume": 96637, "averageVolume": 1867116, "averageVolume10days": 73610, "averageDailyVolume10Day": 73610, "bid": 8.03, "ask": 8.4, "bidSize": 1, "askSize": 1, "marketCap": 18438000, "fiftyTwoWeekLow": 3.08, "fiftyTwoWeekHigh": 597.6, "priceToSalesTrailing12Months": 1843.8, "fiftyDayAverage": 8.1694, "twoHundredDayAverage": 53.3911, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 14176033, "profitMargins": 0.0, "floatShares": 312562, "sharesOutstanding": 2238980, "sharesShort": 64256, "sharesShortPriorMonth": 123114, "sharesShortPreviousMonthDate": 1752537600, "dateShortInterest": 1755216000, "sharesPercentSharesOut": 0.0287, "heldPercentInsiders": 0.65449995, "heldPercentInstitutions": 0.00994, "shortRatio": 0.01, "shortPercentOfFloat": 0.045, "impliedSharesOutstanding": 2238980, "bookValue": 2.29, "priceToBook": 3.5960698, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -6428000, "trailingEps": 7123.5, "forwardEps": -1.99, "lastSplitFactor": "1:15", "lastSplitDate": 1751846400, "enterpriseToRevenue": 1417.603, "enterpriseToEbitda": -1.369, "52WeekChange": -0.96761006, "SandP52WeekChange": 0.16844666, "quoteType": "EQUITY", "currentPrice": 8.235, "recommendationKey": "none", "totalCash": 4275000, "totalCashPerShare": 1.909, "ebitda": -10355000, "totalDebt": 10000, "quickRatio": 5.625, "currentRatio": 5.767, "totalRevenue": 10000, "debtToEquity": 0.275, "revenuePerShare": 0.006, "returnOnAssets": -1.0283101, "returnOnEquity": -2.7680302, "grossProfits": 10000, "freeCashflow": -9424750, "operatingCashflow": -8726000, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -1035.8, "financialCurrency": "USD", "symbol": "CYCC", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Cyclacel Pharmaceuticals, Inc.", "longName": "Cyclacel Pharmaceuticals, Inc.", "regularMarketChangePercent": 5.3069, "regularMarketPrice": 8.235, "marketState": "CLOSED", "postMarketChangePercent": -2.85367, "postMarketPrice": 8.0, "postMarketChange": -0.235, "regularMarketChange": 0.414999, "regularMarketDayRange": "7.74 - 8.82", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1867116, "fiftyTwoWeekLowChange": 5.1549997, "fiftyTwoWeekLowChangePercent": 1.6737013, "fiftyTwoWeekRange": "3.08 - 597.6", "fiftyTwoWeekHighChange": -589.365, "fiftyTwoWeekHighChangePercent": -0.9862199, "fiftyTwoWeekChangePercent": -96.76101, "dividendDate": 1746057600, "earningsTimestampStart": 1754996340, "earningsTimestampEnd": 1755518400, "earningsCallTimestampStart": 1723667400, "earningsCallTimestampEnd": 1723667400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 7123.5, "epsForward": -1.99, "fiftyDayAverageChange": 0.06559944, "fiftyDayAverageChangePercent": 0.008029897, "twoHundredDayAverageChange": -45.1561, "twoHundredDayAverageChangePercent": -0.8457608, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1079447400000, "cryptoTradeable": false, "exchange": "NCM", "messageBoardId": "finmb_125004", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "postMarketTime": 1756511437, "regularMarketTime": 1756497601, "displayName": "Cyclacel Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-08-30"}]